SLU Conducting Study With COVID-19 Booster Vaccine
05/06/2022
Saint Louis University is conducting a study with an investigational COVID-19 booster vaccine.
The purpose of this study is to test investigational booster vaccines for COVID-19. Participants who previously received a two-dose series of an mRNA COVID-19 Emergency Use Authorization (EUA) vaccine (Pfizer or Moderna) with a booster will receive a single booster study vaccination. Participants who previously received an adenovirus-vectored COVID-19 EUA vaccine (Johnson and Johnson/Janssen) with a booster will receive a two-dose booster study vaccination series.
Researchers are seeking participants that are 61 years old or older and are in general
good health.
Participates must have been vaccinated against COVID-19 and also received a booster.
Participation is strictly voluntary. Participants will be compensated . The study will last up to 15 months.
To discuss volunteering, contact a nurse at 314-977-6333 or email vaccine@slu.edu.